To analyze the correlation between c-MET expression and prognosis, we used the Kaplan-Meier Plotter database, showing that pancreatic cancer patients with high c-MET expression (upper quartile) had significantly lower survival rates than those with low expression (lower quartile), with a log-rank test p-value < 0.05. The gene discussed is MET; the disease is familial pancreatic carcinoma.